Position in BMRN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$152,523
-$7,938 QoQ
Shares Held
2,700
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SITTNER & NELSON, LLC holds $893,920 across 13 Biotechnology names. BMRN ranks #3 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
615 | $274,622 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
5,051 | $240,276 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
2,700 | $152,523 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,449 | $93,648 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
95 | $73,400 | |
| 6 | MRNA |
Moderna, Inc.
|
690 | $35,052 | |
| 7 | BNTX |
BioNTech SE
|
100 | $8,888 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
1,000 | $7,670 |
All Filings in BMRN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $152,523 | 2,700 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $160,461 | 2,700 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $151,648 | 2,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $170,407 | 3,100 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $205,001 | 2,900 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $190,617 | 2,900 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $203,841 | 2,900 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $246,990 | 3,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $262,020 | 3,000 | Shares | Sole | 2024-05-10 | |
| 2023-06-30 | $3,900 | 45 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||